0 XP   0   0   0

Dr. Reddy's Laboratories Limited
Buy, Hold or Sell?

Should you buy, hold or sell Dr. Reddy's Laboratories Limited?

I guess you are interested in Dr. Reddy's Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Dr. Reddy's Laboratories Limited

Let's start. I'm going to help you getting a better view of Dr. Reddy's Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Dr. Reddy's Laboratories Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Dr. Reddy's Laboratories Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Dr. Reddy's Laboratories Limited. The closing price on 2023-01-27 was INR4,318 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Dr. Reddy's Laboratories Limited Daily Candlestick Chart
Dr. Reddy's Laboratories Limited Daily Candlestick Chart
Summary









1. Valuation of Dr. Reddy's Laboratories Limited




Current price per share

INR4,318.30

2. Growth of Dr. Reddy's Laboratories Limited




Is Dr. Reddy's Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$2.3b$2.1b$193.1m8.2%

How much money is Dr. Reddy's Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money$268.4m$240m$28.4m10.6%
Net Profit Margin10.1%10.2%--

How much money comes from the company's main activities?

3. Financial Health of Dr. Reddy's Laboratories Limited




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Dr. Reddy's Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dr. Reddy's Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Dr. Reddy's Laboratories Limited to the  industry mean.
  • A Net Profit Margin of 10.1% means that ₹0.10 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 10.1%. The company is making a huge profit. +2
  • The TTM is 10.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.1%0.0%
TTM10.1%YOY10.2%-0.1%
TTM10.1%5Y10.2%-0.1%
5Y10.2%10Y10.0%+0.2%
1.1.2. Return on Assets

Shows how efficient Dr. Reddy's Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dr. Reddy's Laboratories Limited to the  industry mean.
  • 7.3% Return on Assets means that Dr. Reddy's Laboratories Limited generated ₹0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 7.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.3%TTM7.3%0.0%
TTM7.3%YOY7.3%+0.0%
TTM7.3%5Y7.3%+0.1%
5Y7.3%10Y7.0%+0.2%
1.1.3. Return on Equity

Shows how efficient Dr. Reddy's Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dr. Reddy's Laboratories Limited to the  industry mean.
  • 11.4% Return on Equity means Dr. Reddy's Laboratories Limited generated ₹0.11 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 11.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.4%TTM11.4%0.0%
TTM11.4%YOY11.1%+0.3%
TTM11.4%5Y11.4%0.0%
5Y11.4%10Y11.2%+0.1%

1.2. Operating Efficiency of Dr. Reddy's Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dr. Reddy's Laboratories Limited is operating .

  • Measures how much profit Dr. Reddy's Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dr. Reddy's Laboratories Limited to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Dr. Reddy's Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.37 means that the operating costs are ₹0.37 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 0.371. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.371. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.371TTM0.3710.000
TTM0.371YOY0.345+0.027
TTM0.3715Y0.340+0.032
5Y0.34010Y0.332+0.007

1.3. Liquidity of Dr. Reddy's Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dr. Reddy's Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.82 means the company has ₹1.82 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 1.821. The company is able to pay all its short-term debts. +1
  • The TTM is 1.821. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.821TTM1.8210.000
TTM1.821YOY1.795+0.025
TTM1.8215Y1.754+0.067
5Y1.75410Y1.653+0.101
1.3.2. Quick Ratio

Measures if Dr. Reddy's Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dr. Reddy's Laboratories Limited to the  industry mean.
  • A Quick Ratio of 1.44 means the company can pay off ₹1.44 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 1.439. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.439. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.439TTM1.4390.000
TTM1.439YOY1.281+0.158
TTM1.4395Y1.346+0.092
5Y1.34610Y1.261+0.085

1.4. Solvency of Dr. Reddy's Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dr. Reddy's Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dr. Reddy's Laboratories Limited to industry mean.
  • A Debt to Asset Ratio of 0.35 means that Dr. Reddy's Laboratories Limited assets are financed with 35.4% credit (debt) and the remaining percentage (100% - 35.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 0.354. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.354. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.354TTM0.3540.000
TTM0.354YOY0.337+0.017
TTM0.3545Y0.368-0.013
5Y0.36810Y0.379-0.012
1.4.2. Debt to Equity Ratio

Measures if Dr. Reddy's Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dr. Reddy's Laboratories Limited to the  industry mean.
  • A Debt to Equity ratio of 54.8% means that company has ₹0.55 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 0.548. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.548. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.548TTM0.5480.000
TTM0.548YOY0.509+0.040
TTM0.5485Y0.588-0.040
5Y0.58810Y0.620-0.032

2. Market Valuation of Dr. Reddy's Laboratories Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Dr. Reddy's Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Dr. Reddy's Laboratories Limited to the  industry mean.
  • A PE ratio of 37.33 means the investor is paying ₹37.33 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dr. Reddy's Laboratories Limited:

  • The EOD is 32.836. Good. +1
  • The MRQ is 37.325. Good. +1
  • The TTM is 37.325. Good. +1
Trends
Current periodCompared to+/- 
EOD32.836MRQ37.325-4.489
MRQ37.325TTM37.3250.000
TTM37.325YOY44.192-6.867
TTM37.3255Y33.925+3.400
5Y33.92510Y34.810-0.885
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Dr. Reddy's Laboratories Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Dr. Reddy's Laboratories Limited:

  • The MRQ is 33.423. Seems overpriced? -1
  • The TTM is 33.423. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ33.423TTM33.4230.000
TTM33.423YOY45.863-12.440
TTM33.4235Y34.107-0.684
5Y34.10710Y34.1070.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dr. Reddy's Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 4.24 means the investor is paying ₹4.24 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Dr. Reddy's Laboratories Limited:

  • The EOD is 3.730. Neutral. Compare to industry.
  • The MRQ is 4.240. Neutral. Compare to industry.
  • The TTM is 4.240. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.730MRQ4.240-0.510
MRQ4.240TTM4.2400.000
TTM4.240YOY4.889-0.649
TTM4.2405Y3.694+0.547
5Y3.69410Y3.767-0.073
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dr. Reddy's Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--93.16193.1610%123.554-25%83.568+11%192.945-52%
Book Value Growth--1.0891.0890%1.131-4%1.095-1%1.095-1%
Book Value Per Share--1157.6711157.6710%1064.510+9%953.288+21%917.712+26%
Book Value Per Share Growth--1.0881.0880%1.131-4%1.094-1%1.094-1%
Current Ratio--1.8211.8210%1.795+1%1.754+4%1.653+10%
Debt To Asset Ratio--0.3540.3540%0.337+5%0.368-4%0.379-7%
Debt To Equity Ratio--0.5480.5480%0.509+8%0.588-7%0.620-12%
Dividend Per Share--24.98224.9820%25.0230%24.364+3%23.712+5%
Dividend Per Share Growth--0.9980.9980%1.059-6%1.043-4%1.043-4%
Eps--131.510131.5100%117.761+12%109.226+20%104.014+26%
Eps Growth--1.1171.1170%0.964+16%1.182-6%1.182-6%
Free Cash Flow Per Share--54.58654.5860%139.640-61%100.406-46%64.077-15%
Free Cash Flow Per Share Growth--0.3910.3910%0.976-60%1.561-75%1.561-75%
Free Cash Flow To Equity Per Share--39.99239.9920%137.842-71%35.705+12%6.447+520%
Free Cash Flow To Equity Per Share Growth--0.2900.2900%17.946-98%4.104-93%4.104-93%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--532.013--------
Intrinsic Value_10Y_min--456.480--------
Intrinsic Value_1Y_max--54.434--------
Intrinsic Value_1Y_min--52.893--------
Intrinsic Value_3Y_max--162.696--------
Intrinsic Value_3Y_min--153.671--------
Intrinsic Value_5Y_max--269.928--------
Intrinsic Value_5Y_min--247.920--------
Net Profit Margin--0.1010.1010%0.102-1%0.102-1%0.100+1%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.3710.3710%0.345+8%0.340+9%0.332+12%
Pb Ratio3.730-14%4.2404.2400%4.889-13%3.694+15%3.767+13%
Pe Ratio32.836-14%37.32537.3250%44.192-16%33.925+10%34.810+7%
Peg Ratio--33.42333.4230%45.863-27%34.107-2%34.107-2%
Price Per Share4318.300-14%4908.6504908.6500%5204.100-6%3604.260+36%3513.300+40%
Price To Total Gains Ratio36.551-14%41.54841.5480%35.026+19%36.332+14%30.947+34%
Profit Growth--1.1181.1180%0.963+16%1.183-5%1.183-5%
Quick Ratio--1.4391.4390%1.281+12%1.346+7%1.261+14%
Return On Assets--0.0730.0730%0.073+0%0.073+1%0.070+4%
Return On Equity--0.1140.1140%0.111+3%0.1140%0.112+1%
Revenue Growth--1.1311.1310%1.087+4%1.088+4%1.088+4%
Total Gains Per Share--118.143118.1430%148.577-20%107.932+9%216.657-45%
Total Gains Per Share Growth--0.7950.7950%1.248-36%1.166-32%1.166-32%
Usd Book Value--2363125200.0002363125200.0000%2169929100.000+9%1944583260.000+22%1871859100.000+26%
Usd Book Value Change Per Share--1.1461.1460%1.520-25%1.028+11%2.373-52%
Usd Book Value Per Share--14.23914.2390%13.093+9%11.725+21%11.288+26%
Usd Dividend Per Share--0.3070.3070%0.3080%0.300+3%0.292+5%
Usd Eps--1.6181.6180%1.448+12%1.343+20%1.279+26%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Free Cash Flow Per Share--0.6710.6710%1.718-61%1.235-46%0.788-15%
Usd Free Cash Flow To Equity Per Share--0.4920.4920%1.695-71%0.439+12%0.079+520%
Usd Price Per Share53.115-14%60.37660.3760%64.010-6%44.332+36%43.214+40%
Usd Profit--268447500.000268447500.0000%240046800.000+12%222799740.000+20%212154500.000+27%
Usd Revenue--2650059600.0002650059600.0000%2342842500.000+13%2160836940.000+23%2091717500.000+27%
Usd Total Gains Per Share--1.4531.4530%1.828-20%1.328+9%2.665-45%
 EOD+3 -2MRQTTM+0 -0YOY+19 -215Y+24 -1610Y+22 -18

3.2. Fundamental Score

Let's check the fundamental score of Dr. Reddy's Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1532.836
Price to Book Ratio (EOD)Between0-13.730
Net Profit Margin (MRQ)Greater than00.101
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.439
Current Ratio (MRQ)Greater than11.821
Debt to Asset Ratio (MRQ)Less than10.354
Debt to Equity Ratio (MRQ)Less than10.548
Return on Equity (MRQ)Greater than0.150.114
Return on Assets (MRQ)Greater than0.050.073
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Dr. Reddy's Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.334
Ma 20Greater thanMa 504,294.260
Ma 50Greater thanMa 1004,351.856
Ma 100Greater thanMa 2004,344.780
OpenGreater thanClose4,293.350
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets297,469,000
Total Liabilities105,345,000
Total Stockholder Equity192,124,000
 As reported
Total Liabilities 105,345,000
Total Stockholder Equity+ 192,124,000
Total Assets = 297,469,000

Assets

Total Assets297,469,000
Total Current Assets177,823,000
Long-term Assets177,823,000
Total Current Assets
Cash And Cash Equivalents 12,384,000
Short-term Investments 29,513,000
Net Receivables 66,764,000
Inventory 50,884,000
Other Current Assets 3,511,000
Total Current Assets  (as reported)177,823,000
Total Current Assets  (calculated)163,056,000
+/- 14,767,000
Long-term Assets
Property Plant Equipment 61,665,000
Goodwill 5,473,000
Intangible Assets 27,011,000
Long-term Assets  (as reported)0
Long-term Assets  (calculated)94,149,000
+/- 94,149,000

Liabilities & Shareholders' Equity

Total Current Liabilities97,658,000
Long-term Liabilities-
Total Stockholder Equity192,124,000
Total Current Liabilities
Short-term Debt 27,082,000
Total Current Liabilities  (as reported)97,658,000
Total Current Liabilities  (calculated)27,082,000
+/- 70,576,000
Long-term Liabilities
Long term Debt Total 5,746,000
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)5,746,000
+/- 5,746,000
Total Stockholder Equity
Common Stock832,000
Retained Earnings 183,428,000
Capital Surplus 6,701,000
Total Stockholder Equity (as reported)192,124,000
Total Stockholder Equity (calculated)190,961,000
+/- 1,163,000
Other
Cash And Equivalents2,310,000
Cash and Short Term Investments 44,207,000
Common Stock Shares Outstanding 165,957
Liabilities and Stockholders Equity 297,469,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
218,165,000
225,443,000
224,656,000
232,253,000
266,168,000
297,469,000
297,469,000266,168,000232,253,000224,656,000225,443,000218,165,000
   > Total Current Assets 
96,837,000
104,984,000
111,101,000
125,991,000
145,503,000
177,823,000
177,823,000145,503,000125,991,000111,101,000104,984,00096,837,000
       Cash And Cash Equivalents 
1,068,000
1,384,000
1,993,000
1,870,000
5,867,000
12,384,000
12,384,0005,867,0001,870,0001,993,0001,384,0001,068,000
       Short-term Investments 
14,271,000
18,330,000
22,529,000
23,687,000
19,744,000
29,513,000
29,513,00019,744,00023,687,00022,529,00018,330,00014,271,000
       Net Receivables 
37,986,000
40,527,000
39,869,000
50,278,000
49,641,000
66,764,000
66,764,00049,641,00050,278,00039,869,00040,527,00037,986,000
       Inventory 
28,528,000
29,089,000
33,579,000
35,067,000
45,412,000
50,884,000
50,884,00045,412,00035,067,00033,579,00029,089,00028,528,000
       Other Current Assets 
328,000
177,000
484,000
3,483,000
3,226,000
3,511,000
3,511,0003,226,0003,483,000484,000177,000328,000
   > Long-term Assets 000000
       Property Plant Equipment 
56,376,000
57,411,000
53,852,000
52,143,000
56,861,000
61,665,000
61,665,00056,861,00052,143,00053,852,00057,411,00056,376,000
       Goodwill 
4,763,000
5,331,000
4,659,000
4,913,000
5,599,000
5,473,000
5,473,0005,599,0004,913,0004,659,0005,331,0004,763,000
       Intangible Assets 
41,413,000
41,643,000
42,734,000
26,798,000
35,248,000
27,011,000
27,011,00035,248,00026,798,00042,734,00041,643,00041,413,000
> Total Liabilities 
95,544,000
99,727,000
84,420,000
76,265,000
89,751,000
105,345,000
105,345,00089,751,00076,265,00084,420,00099,727,00095,544,000
   > Total Current Liabilities 
84,199,000
68,938,000
58,973,000
72,141,000
81,038,000
97,658,000
97,658,00081,038,00072,141,00058,973,00068,938,00084,199,000
       Short-term Debt 
43,626,000
25,562,000
12,125,000
16,532,000
23,145,000
27,082,000
27,082,00023,145,00016,532,00012,125,00025,562,00043,626,000
   > Long-term Liabilities 000000
       Long term Debt Total 
5,449,000
25,089,000
22,000,000
1,304,000
6,299,000
5,746,000
5,746,0006,299,0001,304,00022,000,00025,089,0005,449,000
> Total Stockholder Equity
122,621,000
125,716,000
140,236,000
155,988,000
176,417,000
192,124,000
192,124,000176,417,000155,988,000140,236,000125,716,000122,621,000
   Common Stock
829,000
830,000
830,000
831,000
832,000
832,000
832,000832,000831,000830,000830,000829,000
   Retained Earnings 
112,243,000
117,781,000
133,520,000
150,147,000
165,604,000
183,428,000
183,428,000165,604,000150,147,000133,520,000117,781,000112,243,000
   Capital Surplus 
4,779,000
5,211,000
5,631,000
5,916,000
6,308,000
6,701,000
6,701,0006,308,0005,916,0005,631,0005,211,0004,779,000
   Treasury Stock0-1,967,000-1,006,000-535,00000
   Other Stockholders Equity 
4,770,000
1,894,000
790,000
100,000
5,640,000
2,764,000
2,764,0005,640,000100,000790,0001,894,0004,770,000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue215,452,000
Cost of Revenue-79,972,000
Gross Profit135,480,000135,480,000
 
Operating Income (+$)
Gross Profit135,480,000
Operating Expense--
Operating Income26,025,000135,480,000
 
Operating Expense (+$)
Research Development-
Selling General Administrative73,399,000
Selling And Marketing Expenses-
Operating Expense-73,399,000
 
Net Interest Income (+$)
Interest Income2,813,000
Interest Expense--
Net Interest Income-2,813,000
 
Pretax Income (+$)
Operating Income26,025,000
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)30,614,00026,025,000
EBIT - interestExpense = 0
21,825,000
21,825,000
Interest Expense-
Earnings Before Interest and Taxes (ebit)-30,614,000
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax30,614,000
Tax Provision-8,833,000
Net Income From Continuing Ops-21,781,000
Net Income21,825,000
Net Income Applicable To Common Shares21,825,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items44,000
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CSPX.LSE
17 minutes ago

I found you a Golden Cross on the daily chart of CSPX.LSE.

CSPX.LSE Daily Candlestick Chart
CRL.LSE
18 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CRL.LSE.

CRL.LSE Daily Candlestick Chart
CRH.LSE
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CRH.LSE.

CRH.LSE Daily Candlestick Chart
ADMIE.AT
19 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ADMIE.AT.

ADMIE.AT Daily Candlestick Chart
DUET.NASDAQ
25 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DUET.NASDAQ.

DUET.NASDAQ Daily Candlestick Chart
POLY.XETRA
49 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of POLY.XETRA.

POLY.XETRA Daily Candlestick Chart
ENTEL.SN
52 minutes ago

I found you a Golden Cross on the daily chart of ENTEL.SN.

ENTEL.SN Daily Candlestick Chart
CENCOSUD.SN
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CENCOSUD.SN.

CENCOSUD.SN Daily Candlestick Chart
ANTARCHILE.SN
53 minutes ago

I found you a Death Cross on the daily chart of ANTARCHILE.SN.

ANTARCHILE.SN Daily Candlestick Chart
3BBE.XETRA
54 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 3BBE.XETRA.

3BBE.XETRA Daily Candlestick Chart
FORUS.SN
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FORUS.SN.

FORUS.SN Daily Candlestick Chart
NGA1L.MI
55 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of NGA1L.MI.

NGA1L.MI Daily Candlestick Chart
3CRE.XETRA
55 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 3CRE.XETRA.

3CRE.XETRA Daily Candlestick Chart
GLGI.OTCQB
57 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GLGI.OTCQB.

GLGI.OTCQB Daily Candlestick Chart
CCMCUA.SW
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CCMCUA.SW.

CCMCUA.SW Daily Candlestick Chart
AUVI.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AUVI.NASDAQ.

AUVI.NASDAQ Daily Candlestick Chart
AUUD.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AUUD.NASDAQ.

AUUD.NASDAQ Daily Candlestick Chart
AUPH.NASDAQ
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of AUPH.NASDAQ.

AUPH.NASDAQ Daily Candlestick Chart
WIB.STU
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WIB.STU.

WIB.STU Daily Candlestick Chart
WFSTF.PINK
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WFSTF.PINK.

WFSTF.PINK Daily Candlestick Chart
WEDXF.PINK
1 hour ago

I found you a Golden Cross on the daily chart of WEDXF.PINK.

WEDXF.PINK Daily Candlestick Chart
WCIG.PINK
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of WCIG.PINK.

WCIG.PINK Daily Candlestick Chart
VISA.NEO
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VISA.NEO.

VISA.NEO Daily Candlestick Chart
BOTZ.SW
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BOTZ.SW.

BOTZ.SW Daily Candlestick Chart